FDA halts use of Regeneron, other monoclonal antibody COVID treatment, DeSantis says move ‘reckless’
(Worthy News) – The Food and Drug Administration has removed two monoclonal antibody therapies from its list of COVID-19 treatments, saying they should not be used in the U.S. because of their ineffectiveness against the virus’ now-dominant Omicron variant.
The agency’s announcement Monday was followed by the Department of Health and Human Services stopping, at least for now, the distribution of the antibody medications made by Regeneron Pharmaceuticals and Eli Lilly, according to The Washington Post.
Regeneron became well known in November 2020 after President Trump received it to treat his COVID infection while the drug was still in early clinical trials and praised its effectiveness. [ Source: Just the News (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌